Drugs / Fecal microbiota transplant G3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03795233 | Aug 2019 → Jan 2021 | Clostridium infectious disease | Boston Medical Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal microbiota transplant G3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03795233 ↗ |
| Known as | FMT | “Fecal Microbiota Transplant (FMT) has been proven a highly efficacious and cost-effective treatment for recurrent CDI.” NCT03795233 ↗ |
| Route | Oral | “30 FMT capsules administered orally under direct observation” NCT03795233 ↗ |